Internal Medicine, Rheumatology · Kansas City, KS
NPI
1972765808
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3901 Rainbow Blvd, 5026 Wescoe, Mailstop 2026
Kansas City, KS, 66160
Phone (913) 588-3402
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
851 services
Medicare patients, 2024
296
Average age 70
Drug cost, 2024
$3.4M
2,330 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul S Schmidt was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 215 times for 161 patients. In total Paul S Schmidt billed 851 services in 17 codes, and Medicare paid $45K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 215 | 161 | $11.61 | $2,495 |
| 99214 Office E&M - Established | Office | 173 | 141 | $67.93 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 119 | 88 | $12.05 | $1,434 |
| 99214 Office E&M - Established | Facility | 68 | 61 | $67.62 | $4,598 |
| 99215 Office E&M - Established | Facility | 62 | 49 | $102.75 | $6,371 |
| 99215 Office E&M - Established | Office | 53 | 48 | $101.81 | $5,396 |
| 99205 Office E&M - New | Office | 26 | 26 | $124.56 | $3,239 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 13 | $90.92 | $1,909 |
| 99232 Hospital E&M - Subsequent | Facility | 19 | 15 | $60.65 | $1,152 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $133.28 | $2,399 |
| 99205 Office E&M - New | Facility | 15 | 15 | $116.54 | $1,748 |
By year: 2022 $43K for 553 services; 2023 $41K for 547 services; 2024 $45K for 851 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul S Schmidt prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 321 prescriptions and refills. In total Paul S Schmidt wrote 2,330 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 321 | 898 | 104 | $13K |
| Prednisone Generic | 270 | 548 | 92 | $2,468 |
| Methotrexate Methotrexate Sodium | 216 | 531 | 64 | $5,948 |
| Mycophenolate Mofetil Generic | 101 | 233 | 27 | $34K |
| Allopurinol Generic | 88 | 250 | 20 | $716 |
| Omeprazole Generic | 74 | 204 | 23 | $621 |
| Humira(Cf) Pen Adalimumab | 65 | 68 | Under 11 | $468K |
| Enbrel Sureclick Etanercept | 57 | 58 | Under 11 | $403K |
| Colchicine Generic | 53 | 137 | 21 | $4,880 |
| Leflunomide Generic | 48 | 137 | 16 | $3,499 |
| Amlodipine Besylate Generic | 48 | 136 | 16 | $219 |
| Cosentyx Sensoready Pen Secukinumab | 44 | 45 | Under 11 | $425K |
| Azathioprine Generic | 42 | 110 | Under 11 | $2,509 |
| Xeljanz Xr Tofacitinib Citrate | 37 | 37 | Under 11 | $217K |
| Folic Acid Generic | 36 | 107 | Under 11 | $327 |
Brand drugs: - claims; generic drugs: 1,768 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul S Schmidt $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.